Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

CEACAM6 (human) monoclonal antibody (9A6)

 
ALX-805-083-C100 100 µg 526.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:CD66c, NCA
 
Clone:9A6
 
Host:Mouse
 
Isotype:IgG1
 
Immunogen:Tumor cell lines expressing human CEACAM6.
 
UniProt ID:P40199
 
Species reactivity:Human
 
Crossreactivity:Does not cross-react with human CEACAM1, 3, 4, 5, 7 or 8.
 
Applications:ELISA, Flow Cytometry, IHC (FS), WB
 
Purity Detail:Protein G-affinity purified.
 
Quality Control:Routinely tested by flow cytometry on BOSC cells transiently transfected with a NCA expression vector.
 
Formulation:Liquid. In PBS, pH 7.2. Contains no preservatives.
 
Handling:For maximum product recovery after thawing, centrifuge the vial before opening the cap. Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C.
 
Shipping:Shipped on Blue Ice
 
Short Term Storage:+4°C
 
Long Term Storage:-20°C
 
Scientific Background:The normal cross-reacting antigen (NCA) or CEACAM6 belongs to the carcinoembryonic antigen (CEA) gene family. CEACAM6 is a GPI-anchored membrane protein with a single N domain, which shows structural homology to the immunoglobulin variable domains, followed by two immunoglobulin constant-like domains.
 
CEACAM6 (human) monoclonal antibody (9A6) image
Figure: Reactivity of FITC-labelled MAb to CEACAM6 (human) (9A6) (Prod. No. ALX-805-083) with polymorph nuclear cells. 2x105 polymorph nuclear cells (PMN) with (green) or without (blue) prior incubation with PMA were reacted for 30 min. at 4°C with FITC conjugated MAb to CEACAM6 (human) (9A6) (40µg/ml) or with an isotype matched FITC-conjugated irrelevant MAb (red), then washed twice. PMN expression of CEACAM6 is constitutively and can be augmented by treatment with PMA."
Please mouse over
CEACAM6 (human) monoclonal antibody (9A6) image

Product Literature References

Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens: T. Schmitter, et al.; J. Exp. Med. 199, 35 (2004), Abstract; Full Text
Carcinoembryonic antigen: W. Zimmermann; Wiley Encyclopedia of Molecular Medicine 459 (2002), (Book chapter),
Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes: B.B. Singer, et al.; J. Immunol. 168, 5139 (2002), Abstract; Full Text
Nuclear factor-kappa B directs carcinoembryonic antigen-related cellular adhesion molecule 1 receptor expression in Neisseria gonorrhoeae-infected epithelial cells: P. Muenzner, et al.; J. Biol. Chem. 277, 7438 (2002), Abstract; Full Text
Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site: S.M. Watt, et al.; Blood 98, 1469 (2001), Abstract; Full Text
Pathogenic Neisseria trigger expression of their carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1; previously CD66a) receptor on primary endothelial cells by activating the immediate early response transcription factor, nuclear facto: P. Muenzner, et al.; J. Biol. Chem. 276, 24331 (2001), Abstract; Full Text
Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas: S. Scholzel, et al.; Am. J. Pathol. 156, 595 (2000), Abstract; Full Text
Carcinoembryonic antigen family receptor specificity of Neisseria meningitidis Opa variants influences adherence to and invasion of proinflammatory cytokine-activated endothelial cells: P. Muenzner, et al.; Infect. Immun. 68, 3601 (2000), Abstract; Full Text
CEA-related proteins on human urothelial cell lines of different transformation grades: A. Krop-Watorek, et al.; Cancer Lett. 139, 15 (1999), Abstract;
Opa binding to cellular CD66 receptors mediates the transcellular traversal of Neisseria gonorrhoeae across polarized T84 epithelial cell monolayers: J. Wang, et al.; Mol. Microbiol. 30, 657 (1998), Abstract; Full Text
CD66 family Workshop: Binding of myeloid blind panel antibodies and CD66 Subsection antibodies to HeLa transfectants expressing individual CD66 molecules: F. Grunert; Leukocyte Typing VI: White cell Differentiation Antigens (1996), Garland Publishing Inc., New York and London, pp. 1012,
Expression of the CEA gene family members NCA-50/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukemias (ALLs) and in cell lines of B-cell origin: H. Hanenberg; Leukemia 12, 2127 (1994), Abstract;
A polymerase-chain-reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)-gene-family members: J. Thompson, et al.; Int. J. Cancer 55, 311 (1993), Abstract;
Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants: S. Daniel, et al.; Int. J. Cancer 55, 303 (1993), Abstract;
Biochemical characterization and tissue distribution of the Cora antigen, a cell surface glycoprotein differentially expressed on malignant and benign gastrointestinal epithelia: H.G. Gottlinger, et al.; Cancer Res. 48, 2198 (1988), Abstract;

General Literature References

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues: S. Hammarstrom; Semin. Cancer Biol. 9, 67 (1999), (Review), Abstract;
Carcinoembryonic antigen gene family: molecular biology and clinical perspectives: J.A. Thompson, et al.; J. Clin. Lab. Anal. 5, 344 (1991), (Review), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
CEACAM
By biological activity:
CEACAM Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,